In the event that the Affordable Care Act is overturned, Republic senators are working on a plan to preserve protections for people with pre-existing conditions and allow children to stay on their parents’ health plan until age 26; urinary tract infections (UTI) are increasingly becoming resistant to antibiotics; a study is highlighting how lifestyle choices can impact dementia risk.
Republican senators are meeting to try and come up with a plan to preserve protections for people with pre-existing conditions and allow children to stay on their parents’ health plan until age 26 in the event that the Affordable Care Act is struck down, The Hill reported. Senator Mitt Romney, R-Utah, is leading the negotiations and is working with Senator Rick Scott, R-Florida, and consulting closely with Senate Judiciary Committee Chairman Lindsey Graham, R-South Carolina, and Senate Health, Education, Labor and Pensions Committee Chairman Lamar Alexander, R-Tennessee, according to the report.
One of the world one of the world's most common ailments, urinary tract infections (UTIs), are increasingly becoming resistant to antibiotics, The New York Times reported. Some UTIs now require heavy-duty treatment with intravenous antibiotics. Besides more restrained use of antibiotics, one possible solution would be the development of rapid, inexpensive diagnostic tools so that providers could broker prescribe the appropriate drug after an instant urine culture; however, running cultures is not standard practice and may be expensive depending on insurance.
A new study says that a healthy lifestyle, such as a good diet, exercise, not smoking, and limiting alcohol, can protect against Alzheimer disease or dementia even if your genes increase your risk, the Associated Press reported. The results, published by JAMA, were presented at the Alzheimer’s Association International Conference last weekend. According to the study findings, people with high genetic risk and poor health habits were approximately 3 times more likely to develop dementia compared with those with low genetic risk and good habits.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More